These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 26419762)
1. Plazomicin: an investigational therapy for the treatment of urinary tract infections. Karaiskos I; Souli M; Giamarellou H Expert Opin Investig Drugs; 2015; 24(11):1501-11. PubMed ID: 26419762 [TBL] [Abstract][Full Text] [Related]
2. Plazomicin: an intravenous aminoglycoside antibacterial for the treatment of complicated urinary tract infections. Bilinskaya A; Linder KE; Kuti JL Expert Rev Anti Infect Ther; 2020 Aug; 18(8):705-720. PubMed ID: 32319833 [TBL] [Abstract][Full Text] [Related]
3. Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections. Eljaaly K; Alharbi A; Alshehri S; Ortwine JK; Pogue JM Drugs; 2019 Feb; 79(3):243-269. PubMed ID: 30723876 [TBL] [Abstract][Full Text] [Related]
4. A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis. Connolly LE; Riddle V; Cebrik D; Armstrong ES; Miller LG Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378708 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of plazomicin against quinolone-resistant gram-negative bacteria isolated from catheter-associated urinary tract infections. Abd-Elmonsef MME; Nagla S; Afandy ME; Maxwell SY J Chemother; 2021 Nov; 33(7):462-468. PubMed ID: 33810779 [TBL] [Abstract][Full Text] [Related]
12. Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms. Castanheira M; Deshpande LM; Woosley LN; Serio AW; Krause KM; Flamm RK J Antimicrob Chemother; 2018 Dec; 73(12):3346-3354. PubMed ID: 30219857 [TBL] [Abstract][Full Text] [Related]
13. Plazomicin for the treatment of patients with complicated urinary tract infection. McCarthy MW Drugs Today (Barc); 2018 Sep; 54(9):513-518. PubMed ID: 30303492 [TBL] [Abstract][Full Text] [Related]
14. Expected plazomicin susceptibility in India based on the prevailing aminoglycoside resistance mechanisms in Gram-negative organisms derived from whole-genome sequencing. Pragasam AK; Jennifer SL; Solaimalai D; Muthuirulandi Sethuvel DP; Rachel T; Elangovan D; Vasudevan K; Gunasekaran K; Veeraraghavan B Indian J Med Microbiol; 2020; 38(3 & 4):313-318. PubMed ID: 33154241 [TBL] [Abstract][Full Text] [Related]
15. Plazomicin (Zemdri) - a new aminoglycoside antibiotic. Med Lett Drugs Ther; 2018 Nov; 60(1559):180-182. PubMed ID: 30681656 [No Abstract] [Full Text] [Related]
16. Application of the Hartford Hospital Nomogram for Plazomicin Dosing Interval Selection in Patients with Complicated Urinary Tract Infection. Asempa TE; Kuti JL; Seroogy JD; Komirenko AS; Nicolau DP Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358580 [TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches. Karaiskos I; Giamarellou H Expert Opin Pharmacother; 2014 Jul; 15(10):1351-70. PubMed ID: 24766095 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Bactericidal Activity of Plazomicin and Comparators against Multidrug-Resistant Enterobacteriaceae. Thwaites M; Hall D; Shinabarger D; Serio AW; Krause KM; Marra A; Pillar C Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866876 [TBL] [Abstract][Full Text] [Related]
20. In vitro activity of Plazomicin against Enterobacteriaceae isolates carrying genes encoding aminoglycoside-modifying enzymes most common in US Census divisions. Castanheira M; Davis AP; Serio AW; Krause KM; Mendes RE Diagn Microbiol Infect Dis; 2019 May; 94(1):73-77. PubMed ID: 30661726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]